Eye disease study tracks 5-Year outcomes and recurrence risks
NCT ID NCT03929731
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 72 people with polypoidal choroidal vasculopathy (PCV), an eye condition that can cause vision loss, for 5 years after their first treatment. Researchers wanted to see how often the disease comes back, what treatments were needed, and if early treatment success led to better long-term vision. The goal is to help doctors predict outcomes and plan better care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYPOIDAL CHOROIDAL VASCULOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National University Hospital
Singapore, Singapore
-
Singapore National Eye Centre
Singapore, Singapore, 168751, Singapore
-
Tan Tock Seng Hospital
Singapore, Singapore, 308433, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.